| 000 | 01235 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513132339.0 | ||
| 264 | 0 | _c19980115 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGygi, M P | |
| 245 | 0 | 0 |
_aRole of endogenous dopamine in the neurochemical deficits induced by methcathinone. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 1997 |
||
| 300 |
_a1350-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aNeurotensin _xanalysis |
| 650 | 0 | 4 |
_aOxidopamine _xpharmacology |
| 650 | 0 | 4 |
_aPropiophenones _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTryptophan Hydroxylase _xmetabolism |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aFleckenstein, A E | |
| 700 | 1 | _aGibb, J W | |
| 700 | 1 | _aHanson, G R | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 283 _gno. 3 _gp. 1350-5 |
|
| 999 |
_c9369666 _d9369666 |
||